5′ and 3′ region variability in the dopamine transporter gene ( SLC6A3 ), pesticide exposure and Parkinson's disease risk: a hypothesis-generating studySamir N. Kelada, Lucio G. Costa, W. T. Longstreth et al.|Human Molecular Genetics|2006Cited by 71
Glutathione S-transferase M1, T1, and P1 Polymorphisms and Parkinson's DiseaseSamir N. Kelada, Harvey Checkoway, Patricia L. Stapleton et al.|Neuroscience Letters|2003Cited by 67
Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's diseaseSamir N. Kelada, Lucio G. Costa, Paola Costa‐Mallen et al.|Pharmacogenetics and Genomics|2005Cited by 58
Gender Difference in the Interaction of Smoking and Monoamine Oxidase B Intron 13 Genotype in Parkinson’s DiseaseSamir N. Kelada, Harvey Checkoway, Paola Costa‐Mallen et al.|NeuroToxicology|2002Cited by 39
DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controlsPaola Costa‐Mallen, Harvey Checkoway, Zahra Afsharinejad et al.|Movement Disorders|2004Cited by 12